Strattera by Ray Sahelian, M.D. atomoxetine

Strattera is the first non-stimulant prescription medication approved for the treatment of attention-deficit/hyperactivity disorder (ADHD) in children, adolescents, and adults. Strattera is a norepinephrine reuptake inhibitor, a class of ADHD treatment that works differently from the other ADHD medications available. Strattera is available by prescription only. Children with ADHD are often treated with the stimulant drug Ritalin, but Strattera, a nonstimulant, has appeal for use in older children and adolescents with ADHD; it is dosed once daily, limited abuse potential, and has a long duration of action.

Strattera for ADHD

Strattera appears to continue to work well for teens with attention deficit/hyperactivity disorder (ADHD) over at least two years, with no major side effects. Dr. Timothy E. Wilens from Massachusetts General Hospital, Boston, says: "Given that Strattera is relatively new to the market, our longer term findings in adolescents are reassuring in that the medication continues to be effective without evidence of tolerance and is well tolerated." The study was supported by Eli Lilly and Company of Indianapolis, Indiana, maker of Strattera.

Strattera side effects
The most common Strattera side effects are nausea, stomach ache, and headache. Rare cases of liver damage due to Strattera has been noted.

Dr. Sahelian says: I would like to wait at least five years of clinical use of Strattera before being as confident as Dr. Timothy Wilens in the safety of strattera.